HANNAH MUSE: Open Payments
NPI 1104513084 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 16 payments from 9 companies in 2025. Trend: 2023 $145 · 2024 $338 · 2025 $279
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $96 |
| Amgen Inc. | 4 | $61 |
| Becton, Dickinson and Company | 1 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| HARMONY BIOSCIENCES LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Edwards Lifesciences Corporation | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| AltaThera Pharmaceuticals LLC | 1 | $10 |
Products named: JARDIANCE, REPATHA, HemoSphere, OPSYNVI, WAKIX, NUCALA, SAPIEN 3 Ultra RESILIA, NEXLETOL.
Industry payments across TX — which companies pay providers there.
